Allergan Inc $170.06

down -0.51


25/7/2014 04:00 PM  |  NYSE : AGN  
Industries : Drugs / Drug Manufacturers - Other
Get Trend Analysis Icon Get AGN Trend Analysis - it has outperformed the S&P 500 by 69%

Partner Headlines

  1. George Soros Reveals His Largest Stake

    GuruFocus
  2. Earnings Season Boosts Confidence; S&P Trades At Record Highs

    Benzinga
  3. BTIG: Valeant Must Sweeten Allergan Bid To More Than $200/Share

    Benzinga
  4. UPDATE: UBS Securities Upgrades Allergan On Conference Call Takeaways

    Benzinga
  5. Allergan EPS Gains Accelerate

    IBD
  6. Allergan Earnings Growth, Job Cuts Counter Valeant

    IBD
  7. UPDATE: Allergan Posts Upbeat Q2 Earnings, Plans To lower 13% Of Workforce

    Benzinga
  8. Allergan to Slash 13% of its Global Workforce

    FoxBusiness
  9. UPDATE: Valeant Complains to SEC Regarding Allergan Claims

    Benzinga
  10. Earnings Scheduled For July 21, 2014

    Benzinga
  11. Stocks To Watch For July 21, 2014

    Benzinga
  12. Pershing Square Releases Letter To Allergan's Board Of Directors, Fund ...

    Benzinga
  13. Valeant Submits HSR Filing Related to Proposed Allergan Deal

    Benzinga
  14. Allergan Issues Comment on Pershing's Definitive Proxy Statement

    Benzinga
  15. Apple And 4 Other Environmentally Responsible Companies

    Benzinga
  16. Benzinga's M&A Chatter for Wednesday July 9, 2014

    Benzinga
  17. Markets Marginally Lower Ahead Of Earnings Season

    Benzinga
  18. Allergan

    IBD
  19. FDA Approves Allergan's Ozurdex, Rejects Levadex

    Benzinga
  20. Sterne Agee Feels More Positive On Allergan Following Recent Call With ...

    Benzinga
  21. Benzinga's Weekend M&A Chatter

    Benzinga
  22. Allergan

    IBD
  23. Stocks Mildly Higher To End The Week

    Benzinga
  24. Top 4 Stocks In The Drug Manufacturers-Other Industry With The Highest ...

    Benzinga
  25. Benzinga's M&A Chatter for Thursday June 26, 2014

    Benzinga
  26. Benzinga's M&A Chatter for Wednesday June 25, 2014

    Benzinga
  27. Paulson builds Allergan stake

    IBD
  28. Rumor: Big Stake In Allergan Acquired By Valeant Supporter Paulson

    Benzinga
  29. Markets Close Higher Despite A Contraction In GDP

    Benzinga
  30. Benzinga's M&A Chatter for Tuesday June 24, 2014

    Benzinga
  31. Walgreen Falls On Weak Earnings, Alliance Boots Reset

    IBD
  32. Bulls Take A Break As Dow's Winning Streak Ends At 7 Days

    Benzinga
  33. 'Merger Monday' Deals, Offers And Rejections

    Benzinga
  34. Allergan Rebuffs Valeant's Tender Offer

    FoxBusiness
  35. Shire Rejects AbbVie's $46 Bil Tax-Inversion Attempt

    IBD
  36. Valeant launches hostile bid

    IBD
  37. M&A Activity Helps Fuel Healthy Action In Drugmakers

    IBD
  38. Benzinga's M&A Chatter for Wednesday June 18, 2014

    Benzinga
  39. Market Wrap For June 18: Markets Rally On Fed Comments And Tapering

    Benzinga
  40. 5-Star Biotech Stock Watch: Synta Pharmaceuticals

    Benzinga
  41. Stocks Meander As Fed Announcement Looms

    IBD
  42. Air Products Soars As CEO Pick Suggests Asset Sales

    IBD
  43. Valeant Goes For Allergan; Analyst Touts Shire Option

    IBD
  44. Allergan, Actavis Top Big Cap Pharmas Amid M&A Flurry

    IBD
  45. Valeant shifts takeover tactics

    IBD
  46. Benzinga's M&A Chatter for Monday June 16, 2014

    Benzinga
  47. Global M&A Up 73% To $1.6 Trillion; Health, Media Top

    IBD
  48. Valeant Pharmaceuticals

    IBD
  49. Shire Up On Report It Proactively Hired Investment Bank

    Benzinga
  50. Market Wrap For June 13: Despite Rising, Dow And S&P 500 Lower For The ...

    Benzinga
Trading Center